Nanoform, a specialist in nanonization technology, has announced the establishment of a wholly owned US subsidiary, citing growing demand for its technology from US pharma companies. Nanoform recently announced the appointment of former Catalent executive Sally Langa as its new Head of US Sales.
In November 2019, Nanoform won the 2019 Excellence in Pharma: Formulation award at CPhI and in December 2019, the company announced that it had submitted an application for GMP certification of its facility in Helsinki, Finland.
Nanoform CEO Edward Hæggström said, “We are tremendously excited to have officially established our presence in the US with a wholly owned subsidiary. This comes as a natural next step for our company as we continue to expand the reach of our nanonization technology.”
Board Vice Chairman Miguel Calado added, “I am thrilled we are establishing Nanoform USA Inc. With this strategic expansion, we now have a strong foundation on which to continue to grow our presence in the US.”
Read the Nanoform press release.
